PubMed Health⌕ Search

Biomedical subjects

J Boller

Publications and source records attributed to J Boller.

7 recordsLinked to original sources

Dexmedetomidine-induced pulmonary alterations in sheep.

Alpha(2) agonist-induced pulmonary oedema in sheep might be related to alterations in pulmonary haemodynamics and/or activation of inflammatory processes. In seven sevoflurane-anaesthetized sheep pulmonary haemodynamics, arterial oxygen tensions, nitric oxide and prostaglandin E(2) concentrations were determined before and after intravenous dexmedetomidine (2microg kg(-1)). In a second trial, lung tissue was sampled for histopathology and quantitative real-time PCR for IL-1beta and iNOS mRNA in a control sheep and 2, 10 and 30min after dexmedetomidine. Computer tomography of the lung under sevoflurane anaesthesia before and after dexmedetomidine was performed. Two minutes after dexmedetomidine mean pulmonary artery pressure, pulmonary arterial occlusion pressure and estimated capillary pressurewere significantly increased to 34.5mmHg, 22.2mmHg and 27.1mmHg, respectively. On computer tomography, lung density increased immediately after dexmedetomidine, with maximal density occurring between 9 and 12min. Histopathology was consistent with vascular congestion followed by protein and erythrocyte extravasation into alveoli. Increased iNOS mRNA levels were detected in sevoflurane anaesthetized animals only. An IL-1beta signal occurred after morphological changes had occurred in lung tissue. These findings support hydrostatic stress as the underlying cause of alpha(2) agonist-induced pulmonary oedema in sheep.

Adrenergic alpha-Agonists↗

Making the critical difference: an innovative approach to educating nurses about organ and tissue donation.

Finding creative solutions to the critical shortage of available organs for transplantation continues to challenge those organizations and health care professionals who are intimately involved in donation procedures. This article describes Making the Critical Difference, an 8-hour continuing education program developed by the National Kidney Foundation and the American Association of Critical-Care Nurses. The program represents a model for identifying and addressing the barriers, attitudes, and needs of nurses as they participate in the donation process.

Education, Nursing, Continuing↗

The nurse moderator role in making the critical difference.

The Making the Critical Difference continuing education program offers the critical care nurse a unique opportunity to assume the nurse moderator role. This article guides the nurse in the preparation for this role by providing detailed explanations and practical advice.

Critical Care↗